18 / 20
Page 42
Journal of Medical Physics and Applied Sciences
ISSN: 2574-285X
I n t e r n a t i o n a l C o n f e r e n c e o n
Nuclear Medicine &
Radiation Therapy
Nuclear Medicine & Radiation Therapy 2018
O c t o b e r 0 1 - 0 2 , 2 0 1 8
S t o c k h o l m , S w e d e n
Radioprotective properties of the anti-cancer preparation
NSC-631570 (UKRAIN)
Wassil Nowicky
Nowicky Pharma/ Ukrainian Anti-Cancer Institute, Austria
Biography
Wassil Nowicky (Dipl Ing, Dr techn, DDD rh c) is the Director
of Nowicky Pharma and President of the Ukrainian Anti-Cancer
Institute (Vienna, Austria). He is the Inventor of NSC-631570,
the anticancer preparation on basis of celandine alkaloids. He
is the Author of over 300 scientific articles dedicated to cancer
research. He is a real Member of the New York Academy of Sci-
ences, Member of the European Union for applied immunology
and of the American Association for scientific progress, hon-
orary Doctor of the Yanka Kupala State University of Grodno,
doctor
Honoris Causa
of the Open International University for
Complementary Medicine in Colombo, Honorary Member of
the Austrian Society on the Name of Albert Schweizer. He has
received merits of National Guild of the award of Austrian Soci-
ety of sanitary, hygiene and public health services and others.
dr.nowicky@yahoo.deW
hen NSC-631570 has been used in clinic, it was observed that the patients
treatedwith this drug tolerate the concomitant radiotherapymuch better. The
adverse effects of this aggressive treatment modality were significantly reduced
to minimal. This gave reason to study radioprotective properties of NSC‐631570 in
the
in vitro
and
in vivo
tests. It was proven the radioprotective effect of NSC‐631570
was far superior compared to such of its raw materials taken separately, both
measured by survival of mice irradiated by different doses and by the protection
coefficient. For example, at adoseof 5.25Gy, protection coefficient of NSC‐631570
was 95.0±4.6 vs 50.8±4.6 in the control. These observations suggested that
the radio protective effect of UKRAIN differs significantly from such of its raw
material. NSC‐631570 was effective in the therapy of recurring respiratory
diseases in children from the Chernobyl area. A total of 38 children from areas of
radiation contaminated after the chernobyl accident and suffering from recurrent
respiratory diseases were included into the study. UKRAIN was administered
intravenously at a dose of 5 mg twice a week, up to a total dose of 35 mg. The
control group received standard therapy. In the UKRAIN treated groupmarked anti‐
inflammatory effect was revealed compared to the control: normalisation of WBC
count and blood sedimentation rate. The immune modulating effect of UKRAIN
was indicated through the improvement in specific humoral and cellular immunity:
increased the IgG concentration, the phagocytic activity of neutrophils, the number
of total lymphocytes, Tlymphocytes and Thelpers, and the helpers/suppressors
ratio.
Wassil Nowicky, J. med phys & appl sci 2018, Volume: 3
DOI: 10.21767/2574-285X-C1-002